• Eric Sagonowsky
• 19 Apr, 2021

Before COVID-19 hit, daily headlines swirled around pharma’s role in the opioid crisis and lawsuits piled up against drugmakers. The pandemic delayed those legal fights. But now, the reprieve is over: A major trial is slated to kick off Monday in California. Johnson & Johnson, AbbVie’s Allergan business, Teva and Endo are set to face a virtual trial over allegations they downplayed risks of opioid addiction to boost sales of the powerful painkillers, according to reports.
Read more...